Literature DB >> 22786586

Retinopathy and risk of dementia: the Rotterdam Study.

Elisabeth M C Schrijvers1, Gabriëlle H S Buitendijk, M Kamran Ikram, Peter J Koudstaal, Albert Hofman, Johannes R Vingerling, Monique M B Breteler.   

Abstract

OBJECTIVE: To investigate the relation between retinopathy and the risk of dementia.
METHODS: We investigated the associations between retinopathy and dementia and its subtypes Alzheimer disease (AD) and vascular dementia both cross-sectionally and prospectively in the Rotterdam Study, a large population-based cohort study. Digitized retinal images were available for 195 participants with prevalent dementia and 6,078 participants without dementia at baseline (1990-1993). Participants were reexamined in 1993-1994, 1997-1999, and 2002-2004 and were continuously monitored for development of dementia until January 1, 2007. Retinopathy was graded on fundus photographs and was defined as the presence of one or more dot/blot hemorrhages, microaneurysms, cotton wool spots, or evidence of laser treatment for retinopathy.
RESULTS: Retinopathy was associated with prevalent dementia (age and sex-adjusted odds ratio 2.04, 95% confidence interval [CI] 1.34-3.09). Results were similar for AD and vascular dementia. During a mean follow-up of 11.4 years, 735 participants developed incident dementia, of whom 583 had AD and 80 had vascular dementia. There was no association of retinopathy at baseline with the risk of incident dementia during follow-up (age- and sex-adjusted hazard ratio 1.15, 95% CI 0.88-1.48) or the risk of incident AD or vascular dementia.
CONCLUSIONS: Retinopathy is more prevalent in persons with dementia but is not associated with an increased risk of dementia over time.

Entities:  

Mesh:

Year:  2012        PMID: 22786586      PMCID: PMC3400091          DOI: 10.1212/WNL.0b013e318260cd7e

Source DB:  PubMed          Journal:  Neurology        ISSN: 0028-3878            Impact factor:   9.910


  21 in total

1.  Retinal vascular caliber and risk of dementia: the Rotterdam study.

Authors:  F J de Jong; E M C Schrijvers; M K Ikram; P J Koudstaal; P T V M de Jong; A Hofman; J R Vingerling; M M B Breteler
Journal:  Neurology       Date:  2011-02-02       Impact factor: 9.910

2.  Where vascular meets neurodegenerative disease.

Authors:  Julie A Schneider; David A Bennett
Journal:  Stroke       Date:  2010-10       Impact factor: 7.914

3.  Retinal microvascular signs and 10-year risk of cerebral atrophy: the Atherosclerosis Risk in Communities (ARIC) study.

Authors:  Ryo Kawasaki; Ning Cheung; Thomas Mosley; Amirul F M Islam; A Richey Sharrett; Ronald Klein; Laura H Coker; David S Knopman; Dean K Shibata; Diane Catellier; Tien Y Wong
Journal:  Stroke       Date:  2010-06-24       Impact factor: 7.914

4.  Cerebral microbleeds, retinopathy, and dementia: the AGES-Reykjavik Study.

Authors:  C Qiu; M F Cotch; S Sigurdsson; P V Jonsson; M K Jonsdottir; S Sveinbjrnsdottir; G Eiriksdottir; R Klein; T B Harris; M A van Buchem; V Gudnason; L J Launer
Journal:  Neurology       Date:  2010-12-14       Impact factor: 9.910

Review 5.  Retinal microvascular abnormalities and their relationship with hypertension, cardiovascular disease, and mortality.

Authors:  T Y Wong; R Klein; B E Klein; J M Tielsch; L Hubbard; F J Nieto
Journal:  Surv Ophthalmol       Date:  2001 Jul-Aug       Impact factor: 6.048

6.  Retinal microvascular abnormalities and subclinical magnetic resonance imaging brain infarct: a prospective study.

Authors:  Ning Cheung; Thomas Mosley; Amirul Islam; Ryo Kawasaki; A Richey Sharrett; Ronald Klein; Laura H Coker; David S Knopman; Dean K Shibata; Diane Catellier; Tien Y Wong
Journal:  Brain       Date:  2010-06-02       Impact factor: 13.501

7.  Retinal microvascular abnormalities and cognitive decline: the ARIC 14-year follow-up study.

Authors:  S R Lesage; T H Mosley; T Y Wong; M Szklo; D Knopman; D J Catellier; S R Cole; R Klein; J Coresh; L H Coker; A R Sharrett
Journal:  Neurology       Date:  2009-09-15       Impact factor: 9.910

8.  Retinal microvascular abnormalities and cognitive impairment in middle-aged persons: the Atherosclerosis Risk in Communities Study.

Authors:  Tien Yin Wong; Ronald Klein; A Richey Sharrett; F Javier Nieto; Lori L Boland; David J Couper; Thomas H Mosley; Barbara E K Klein; Larry D Hubbard; Moyses Szklo
Journal:  Stroke       Date:  2002-06       Impact factor: 7.914

9.  Retinal microvascular signs, cognitive function, and dementia in older persons: the Cardiovascular Health Study.

Authors:  Michelle L Baker; Emily K Marino Larsen; Lewis H Kuller; Ronald Klein; Barbara E K Klein; David S Siscovick; Charles Bernick; Teri A Manolio; Tien Yin Wong
Journal:  Stroke       Date:  2007-05-24       Impact factor: 7.914

10.  The Rotterdam Study: 2012 objectives and design update.

Authors:  Albert Hofman; Cornelia M van Duijn; Oscar H Franco; M Arfan Ikram; Harry L A Janssen; Caroline C W Klaver; Ernst J Kuipers; Tamar E C Nijsten; Bruno H Ch Stricker; Henning Tiemeier; André G Uitterlinden; Meike W Vernooij; Jacqueline C M Witteman
Journal:  Eur J Epidemiol       Date:  2011-08-30       Impact factor: 8.082

View more
  21 in total

1.  Retinal signs and risk of incident dementia in the Atherosclerosis Risk in Communities study.

Authors:  Jennifer A Deal; A Richey Sharrett; Marilyn Albert; Karen Bandeen-Roche; Sheila Burgard; Sonia Davis Thomas; Rebecca F Gottesman; David Knopman; Thomas Mosley; Barbara Klein; Ronald Klein
Journal:  Alzheimers Dement       Date:  2018-11-12       Impact factor: 21.566

Review 2.  Retinal microvascular network alterations: potential biomarkers of cerebrovascular and neural diseases.

Authors:  Delia Cabrera DeBuc; Gabor Mark Somfai; Akos Koller
Journal:  Am J Physiol Heart Circ Physiol       Date:  2016-12-06       Impact factor: 4.733

3.  Coffee consumption and incident dementia.

Authors:  Saira Saeed Mirza; Henning Tiemeier; Renée F A G de Bruijn; Albert Hofman; Oscar H Franco; Jessica Kiefte-de Jong; Peter J Koudstaal; M Arfan Ikram
Journal:  Eur J Epidemiol       Date:  2014-08-26       Impact factor: 8.082

4.  Spectral-Domain OCT Measurements in Alzheimer's Disease: A Systematic Review and Meta-analysis.

Authors:  Victor T T Chan; Zihan Sun; Shumin Tang; Li Jia Chen; Adrian Wong; Clement C Tham; Tien Y Wong; Christopher Chen; M Kamran Ikram; Heather E Whitson; Eleonora M Lad; Vincent C T Mok; Carol Y Cheung
Journal:  Ophthalmology       Date:  2018-08-13       Impact factor: 12.079

5.  Ophthalmic conditions associated with dementia risk: The Cardiovascular Health Study.

Authors:  Phillip H Hwang; Will T Longstreth; Stephen M Thielke; Courtney E Francis; Marco Carone; Lewis H Kuller; Annette L Fitzpatrick
Journal:  Alzheimers Dement       Date:  2021-03-31       Impact factor: 21.566

Review 6.  Associations between retinal microvascular changes and dementia, cognitive functioning, and brain imaging abnormalities: a systematic review.

Authors:  Sophie M Heringa; Willem H Bouvy; Esther van den Berg; Annette C Moll; L Jaap Kappelle; Geert Jan Biessels
Journal:  J Cereb Blood Flow Metab       Date:  2013-04-17       Impact factor: 6.200

7.  Diabetic Retinopathy and Dementia in Type 1 Diabetes.

Authors:  Liora G Rodill; Lieza G Exalto; Paola Gilsanz; Geert Jan Biessels; Charles P Quesenberry; Rachel A Whitmer
Journal:  Alzheimer Dis Assoc Disord       Date:  2018 Apr-Jun       Impact factor: 2.703

8.  Severe diabetic retinal disease and dementia risk in type 2 diabetes.

Authors:  Lieza G Exalto; Geert Jan Biessels; Andrew J Karter; Elbert S Huang; Charles P Quesenberry; Rachel A Whitmer
Journal:  J Alzheimers Dis       Date:  2014       Impact factor: 4.472

Review 9.  Hypertensive eye disease.

Authors:  Carol Y Cheung; Valérie Biousse; Pearse A Keane; Ernesto L Schiffrin; Tien Y Wong
Journal:  Nat Rev Dis Primers       Date:  2022-03-10       Impact factor: 52.329

10.  Retinal Vascular Changes and Prospective Risk of Disabling Dementia: the Circulatory Risk in Communities Study (CIRCS).

Authors:  Hiroshige Jinnouchi; Akihiko Kitamura; Kazumasa Yamagishi; Masahiko Kiyama; Hironori Imano; Takeo Okada; Renzhe Cui; Mitsumasa Umesawa; Isao Muraki; Mina Hayama-Terada; Ryo Kawasaki; Tomoko Sankai; Tetsuya Ohira; Hiroyasu Iso
Journal:  J Atheroscler Thromb       Date:  2016-12-01       Impact factor: 4.928

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.